| Literature DB >> 32238342 |
Andrew J King1,2, Gregory F Cooper1,3, Gilles Clermont2, Harry Hochheiser1,3, Milos Hauskrecht4, Dean F Sittig5, Shyam Visweswaran1,3.
Abstract
BACKGROUND: Electronic medical record (EMR) systems capture large amounts of data per patient and present that data to physicians with little prioritization. Without prioritization, physicians must mentally identify and collate relevant data, an activity that can lead to cognitive overload. To mitigate cognitive overload, a Learning EMR (LEMR) system prioritizes the display of relevant medical record data. Relevant data are those that are pertinent to a context-defined as the combination of the user, clinical task, and patient case. To determine which data are relevant in a specific context, a LEMR system uses supervised machine learning models of physician information-seeking behavior. Since obtaining information-seeking behavior data via manual annotation is slow and expensive, automatic methods for capturing such data are needed.Entities:
Keywords: electronic medical record system; eye tracking; information-seeking behavior; intensive care unit; machine learning
Year: 2020 PMID: 32238342 PMCID: PMC7163414 DOI: 10.2196/15876
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Figure 1A computer monitor displaying the Learning Electronic Medical Record user interface with an eye-tracking device mounted at the bottom edge of the monitor. The interface temporally displays patient medical record data in four scrollable panels: (from left to right) panel 1 contains vital signs, ventilator settings, and intake and output; panel 2 contains medication administrations; panel 3 contains laboratory test results; and panel 4 contains free-text notes and reports. The remote eye-tracking device is magnetically attached to the bottom edge of the monitor and connected to the computer via a universal serial bus cable (screenshot is of a deidentified patient case).
Characteristics of reviewers.
| Phase of study | Number of reviewers | Time in years since medical school graduation, mean (SD) | Time in years spent in ICUa, mean (SD) | Weeks per year spent rounding in the ICU, mean (SD) |
| Training | 11 | 5.3 (3.0-10.0) | 1.8 (0.3-7.0) | 34 (26-42) |
| Evaluation | 12 | 5.4 (3.0-11.0) | 1.7 (0.6-4.0) | 36 (28-44) |
aICU: intensive care unit.
Summary of data sets, models trained, and models evaluated. Each model predicts if a single electronic medical record data item is relevant.
| Data set | Counts | ||
|
| Number of patient cases | Number of models trained | Number of models evaluated (using the manual-selection evaluation data set) |
| Manual selection training | 134 | 87 | 68 |
| Gaze-derived training | 134 | 115 | 68 |
| Manual selection evaluation | 68 | — | — |
Summary of machine learning methods, imputation methods, number of models of each combination of machine learning and imputation methods, and number of features per model.
| Machine learning and imputation method | Manual selection | Gaze-derived | |||
|
| Number of models | Features per model mean | Number of models | Features per model mean | |
|
|
|
|
|
| |
|
| Median | 18 | 207.4 | 24 | 176.3 |
|
| Regression | 10 | 659.2 | 15 | 304.9 |
|
|
|
|
|
| |
|
| Median | 18 | 2366.3 | 9 | 2108.9 |
|
| Regression | 0 | — | 0 | — |
|
|
|
|
|
| |
|
| Median | 27 | 336.0 | 37 | 341.9 |
|
| Regression | 14 | 806.1 | 30 | 613.8 |
Figure 2Performance of models used to predict the relevance of targets. The x-axis value and y-axis value of each point indicate the area under the receiver operating characteristic curve (AUROC) values of a pair of manual selection and gaze-derived models, respectively. The vertical and horizontal lines indicate 95% confidence intervals of the AUROC values. The diagonal line indicates equal performance between manual selection and gaze-derived models. Red triangles indicate model pairs where the AUROC value of one model is significantly different than that of the other model (α=.05).
Area under the receiver operating characteristic curve values (with 95% confidence intervals) on the evaluation data set of manual selection and gaze-derived models for predicting relevance of targets. Rows are sorted by manual selection performance.
| Target | Number of positive samples in evaluation data set | Manual selection models | Gaze-derived models |
| Alanine aminotransferase | 10 | 0.97a (1.00, 0.96) | 0.90 (0.96, 0.83) |
| Aspartate aminotransferase | 10 | 0.96a (1.00, 0.93) | 0.70 (0.80, 0.59) |
| Norepinephrine | 13 | 0.85 (0.93, 0.77) | 0.82 (0.90, 0.73) |
| Levothyroxine | 1 | 0.81 (0.85, 0.75) | 0.99a (1.00, 0.97) |
| Fraction of inspired oxygen | 27 | 0.77 (0.86, 0.66) | 0.71 (0.80, 0.59) |
| Vancomycin | 17 | 0.76a (0.87, 0.65) | 0.61 (0.73, 0.50) |
| Total bilirubin | 12 | 0.75a (0.85, 0.60) | 0.38 (0.54, 0.21) |
| Bicarbonate, arterial | 1 | 0.75 (0.83, 0.66) | 0.85 (0.91, 0.78) |
| Aspirin | 3 | 0.72a (0.80, 0.62) | 0.12 (0.19, 0.06) |
| pH | 6 | 0.71a (0.85, 0.56) | 0.53 (0.70, 0.38) |
| Troponin | 3 | 0.71 (0.79, 0.61) | 1.00a (1.00, 1.00) |
| Lactate | 11 | 0.70 (0.83, 0.57) | 0.62 (0.76, 0.49) |
| Temperature | 42 | 0.70a (0.81, 0.58) | 0.48 (0.61, 0.37) |
| Lorazepam | 3 | 0.70 (0.80, 0.62) | 0.65 (0.74, 0.56) |
| Ventilator mode | 20 | 0.70 (0.80, 0.58) | 0.64 (0.76, 0.52) |
| Dextrose in water | 3 | 0.69 (0.92, 0.36) | 0.67 (0.98, 0.27) |
| Partial pressure of oxygen | 6 | 0.67a (0.89, 0.45) | 0.36 (0.59, 0.15) |
| Bilirubin direct | 9 | 0.67 (0.81, 0.55) | 0.52 (0.63, 0.35) |
| Heparin | 16 | 0.65 (0.77, 0.52) | 0.62 (0.76, 0.46) |
| Ionized calcium | 1 | 0.65 (0.75, 0.56) | 0.58 (0.68, 0.49) |
| Propofol | 6 | 0.64 (0.87, 0.40) | 0.55 (0.85, 0.25) |
| Piperacillin-tazobactam | 15 | 0.64 (0.81, 0.45) | 0.48 (0.63, 0.31) |
| Famotidine | 6 | 0.64a (0.77, 0.50) | 0.41 (0.63, 0.21) |
| Potassium | 26 | 0.63 (0.73, 0.50) | 0.49 (0.63, 0.39) |
| White blood cells | 50 | 0.61 (0.74, 0.48) | 0.60 (0.71, 0.47) |
| Bands | 15 | 0.60a (0.75, 0.47) | 0.34 (0.49, 0.21) |
| Vancomycin trough | 4 | 0.59 (0.87, 0.31) | 0.59 (0.99, 0.19) |
| Blood urea nitrogen | 30 | 0.59 (0.70, 0.47) | 0.58 (0.69, 0.46) |
| Intravenous base solution | 19 | 0.58 (0.72, 0.45) | 0.48 (0.61, 0.35) |
| Oxygen saturation | 29 | 0.57 (0.69, 0.46) | 0.50 (0.63, 0.40) |
| Intake and output | 43 | 0.57 (0.69, 0.44) | 0.58 (0.71, 0.46) |
| Heart rate | 42 | 0.55 (0.66, 0.41) | 0.59 (0.71, 0.46) |
| Prothrombin time | 4 | 0.53 (0.81, 0.27) | 0.73 (0.94, 0.48) |
| Pantoprazole | 9 | 0.53 (0.71, 0.40) | 0.64 (0.77, 0.48) |
| Bicarbonate, venous | 15 | 0.53 (0.68, 0.40) | 0.55 (0.69, 0.43) |
| Glomerular filtration rate | 1 | 0.53a (0.63, 0.44) | 0.40 (0.50, 0.31) |
| Hydrocortisone | 5 | 0.52a (0.77, 0.27) | 0.31 (0.58, 0.10) |
| Metoprolol | 7 | 0.52a (0.70, 0.34) | 0.30 (0.45, 0.16) |
| Glucose | 21 | 0.51 (0.64, 0.39) | 0.51 (0.63, 0.38) |
| Insulin | 13 | 0.50 (0.65, 0.37) | 0.51 (0.67, 0.36) |
| Platelets | 30 | 0.50 (0.63, 0.39) | 0.42 (0.54, 0.31) |
| Respiratory rate | 17 | 0.49 (0.61, 0.36) | 0.59 (0.71, 0.45) |
| Central venous pressure | 2 | 0.47 (0.68, 0.27) | 0.64 (0.99, 0.26) |
| Creatinine | 59 | 0.47 (0.67, 0.28) | 0.40 (0.58, 0.23) |
| Magnesium | 9 | 0.47 (0.60, 0.36) | 0.56 (0.72, 0.39) |
| Albumin | 1 | 0.46 (0.55, 0.35) | 0.72a (0.80, 0.63) |
| Phosphate | 12 | 0.45 (0.59, 0.33) | 0.54 (0.72, 0.37) |
| Sodium | 41 | 0.45 (0.56, 0.31) | 0.48 (0.61, 0.36) |
| Chloride | 12 | 0.44 (0.59, 0.29) | 0.39 (0.56, 0.23) |
| Blood pressure | 61 | 0.43 (0.64, 0.22) | 0.53 (0.75, 0.33) |
| Chlorhexidine topical | 6 | 0.43 (0.60, 0.25) | 0.48 (0.71, 0.26) |
| Partial thromboplastin time | 1 | 0.43a (0.54, 0.34) | 0.30 (0.40, 0.22) |
| Hemoglobin | 31 | 0.41 (0.53, 0.30) | 0.49 (0.61, 0.38) |
| Neutrophils | 4 | 0.39 (0.64, 0.21) | 0.45 (0.77, 0.16) |
| Fentanyl | 14 | 0.39 (0.53, 0.26) | 0.64a (0.78, 0.50) |
| Metronidazole | 13 | 0.39 (0.51, 0.22) | 0.44 (0.59, 0.29) |
| Furosemide | 3 | 0.39 (0.50, 0.27) | 0.40 (0.92, 0.09) |
| Calcium | 2 | 0.37 (0.54, 0.19) | 0.24 (0.43, 0.06) |
| Sodium chloride | 28 | 0.37 (0.50, 0.25) | 0.44 (0.54, 0.30) |
| International normalized ratio | 11 | 0.35 (0.52, 0.19) | 0.68a (0.81, 0.55) |
| Midazolam | 2 | 0.35 (0.51, 0.21) | 0.65a (0.79, 0.51) |
| Alkaline phosphatase | 5 | 0.33 (0.58, 0.08) | 0.78a (0.93, 0.64) |
| Acetaminophen | 1 | 0.31 (0.40, 0.22) | 0.80a (0.87, 0.71) |
| Ventilator tube status | 9 | 0.30 (0.45, 0.16) | 0.48 (0.65, 0.31) |
| Albuterol-ipratropium | 5 | 0.29 (0.49, 0.09) | 0.69 (0.97, 0.41) |
| Mean corpuscular volume | 2 | 0.27 (0.58, 0.02) | 0.14 (0.19, 0.09) |
| Partial pressure of carbon dioxide | 4 | 0.27 (0.36, 0.18) | 0.45 (0.61, 0.29) |
| Ventilator status | 2 | 0.16 (0.34, 0.02) | 0.43 (0.61, 0.24) |
aIndicates statistically significant difference at α=.05.